Corpus Intelligence IC Memo — RUSSELL COUNTY HOSPITAL 2026-04-26 05:02 UTC
IC Memo — RUSSELL COUNTY HOSPITAL
Investment Committee Memorandum | VA | 48 beds | Grade C | EBITDA uplift $2.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

RUSSELL COUNTY HOSPITAL

CCN 490002 | RUSSELL, VA | 48 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

RUSSELL COUNTY HOSPITAL is a 48-bed suburban community hospital in RUSSELL, VA with $36.5M in net patient revenue and a 19.9% operating margin. The hospital serves a payer mix of 24.4% Medicare, 0.8% Medicaid, and 74.8% commercial.

Thesis: Turnaround. Our ML models identify $2.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 19.9% to 27.3% (+736bps).

Net Revenue HCRIS$36.5M
Current EBITDA COMPUTED$7.3M
Operating Margin COMPUTED19.9%
Occupancy HCRIS44.3%
Revenue / Bed COMPUTED$759K
Net-to-Gross HCRIS26.6%
Distress Probability ML48.6%

2. Market Context & Competitive Position

111
VA Hospitals
4.4%
State Median Margin
47
Comparable Hospitals

VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of 19.9% places it above the state median. Among 47 size-comparable peers (24-96 beds), the median margin is 5.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (24-96), prioritizing same-state peers. 47 hospitals in the comp set.

HospitalStateBedsRevenueMargin
RUSSELL COUNTY HOSPITAL (Target)VA48$36.5M19.9%
CARILION NEW RIVER VALLEY MED VA94$261.3M-0.5%
RICHMOND COMMUNITY HOSPITALVA96$254.9M21.5%
LONESOME PINE HOSPITALVA56$175.6M17.2%
LEWISGALE HOSPITAL - MONTGOMERVA92$155.7M40.7%
CULPEPER MEMORIAL HOSPITALVA70$153.9M9.3%
COMMUNITY MEMORIAL HOSPITALVA66$135.2M-31.0%
STAFFORD HOSPITALVA61$127.9M5.7%
SOUTHSIDE COMMUNITY HOSPITALVA80$113.4M7.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$765K+210bp18mo
Cost to Collect4.5%2.5%$729K+200bp12mo
Denial Rate Reduction12.0%6.5%$722K+198bp12mo
A/R Days Reduction5200.0%3800.0%$444K+122bp9mo
Clean Claim Rate88.0%96.0%$23K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$765K
Cost to Collect
$729K
Denial Rate Reduction
$722K
A/R Days Reduction
$444K
Clean Claim Rate
$23K
Total EBITDA Uplift$2.7M
Current EBITDA$7.3M
+ RCM Uplift+$2.7M
Pro Forma EBITDA$10.0M
Current Margin19.9%
Pro Forma Margin27.3%
WC Released (1x)$1.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$11.2M$74.8M6.69x46.2%
Base (11x exit)10.0x11.0x$11.2M$85.9M7.68x50.3%
Bull Case9.0x11.0x$10.1M$98.4M9.77x57.8%
Bull (12x exit)9.0x12.0x$10.1M$110.3M10.96x61.4%
Bear Case11.0x10.0x$12.3M$57.7M4.69x36.2%
Bear (11x exit)11.0x11.0x$12.3M$67.5M5.49x40.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 47 hospitals with 24-96 beds
  • Same-state prioritization (n=48)
  • Comp margins: P25=-11.3% / P50=5.7% / P75=14.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.